The DOI matches its Crossref record; 491 of the 491 references it cites were found in a registry or an index.
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Open accessAbstract
Ferroptosis is a non-apoptotic form of regulated cell death characterized by the lethal accumulation of iron-dependent membrane-localized lipid peroxides. It acts as an innate tumor suppressor mechanism and participates in the biological processes of tumors. Intriguingly, mesenchymal and dedifferentiated cancer cells, which are usually resistant to apoptosis and traditional therapies, are exquisitely vulnerable to ferroptosis, further underscoring its potential as a treatment approach for cancers, especially for refractory cancers. However, the impact of ferroptosis on cancer extends beyond its direct cytotoxic effect on tumor cells. Ferroptosis induction not only inhibits cancer but also promotes cancer development due to its potential negative impact on anticancer immunity. Thus, a comprehensive understanding of the role of ferroptosis in cancer is crucial for the successful translation of ferroptosis therapy from the laboratory to clinical applications. In this review, we provide an overview of the recent advancements in understanding ferroptosis in cancer, covering molecular mechanisms, biological functions, regulatory pathways, and interactions with the tumor microenvironment. We also summarize the potential applications of ferroptosis induction in immunotherapy, radiotherapy, and systemic therapy, as well as ferroptosis inhibition for cancer treatment in various conditions. We finally discuss ferroptosis markers, the current challenges and future directions of ferroptosis in the treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–491 of 491
You, J. H., Lee, J., & Roh, J. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.013 · Cited by 98
Ni, J., Chen, K., Zhang, J., & Zhang, X. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.06.051 · Cited by 97
Jiang, K., Yin, X., Zhang, Q., Yin, J., Tang, Q., Xu, M., Wu, L., Shen, Y., Zhou, Z., Yu, H., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102626 · Cited by 97
Borchert, A., Kalms, J., Roth, S. R., Rademacher, M., Schmidt, A., Holzhütter, H., Kühn, H., & Scheerer, P. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.006 · Cited by 95
Multifaceted mechanisms mediating cystine starvation-induced ferroptosis
Shi, Z., Naowarojna, N., Pan, Z., & Zou, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-25159-5 · Cited by 94
Luo, Y., Chen, Y., Jin, H., Hou, B., Li, H., Li, X., Liu, L., Zhou, Y., Li, Y., Song, Y. S., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.03.025 · Cited by 92
Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation
Shindo, R., Kakehashi, H., Okumura, K., Kumagai, Y., & Nakano, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.075 · Cited by 91
Antiferroptotic activity of non-oxidative dopamine
Wang, D., Peng, Y., Xie, Y., Zhou, B., Sun, X., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.099 · Cited by 91
Yang, X., Liu, J., Wang, C., Cheng, K. K. Y., Xu, H., Li, Q., Hua, T., Jiang, X., Sheng, L., Mao, J., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00304-3 · Cited by 89
Lv, M., Gong, Y., Liu, X., Wang, Y., Wu, Q., Chen, J., Min, Q., Zhao, D., Li, X., Chen, D., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01555-9 · Cited by 89
Oliveira, T. G., Hermann, E. R., Lin, D., Chowanadisai, W., Hull, E. E., & Montgomery, M. R. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102149 · Cited by 88
MLL4 mediates differentiation and tumor suppression through ferroptosis
Egolf, S., Zou, J., Anderson, A., Simpson, C. L., Aubert, Y., Prouty, S., Ge, K., Seykora, J. T., & Capell, B. C. (2021) · Science Advances · doi:10.1126/sciadv.abj9141 · Cited by 88
Sun, R., Lin, Z., Wang, X., Liu, L., Huo, M., Zhang, R., Lin, J., Xiao, C., Li, Y., Zhu, W., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02493-0 · Cited by 88
Zhang, Y., Li, S., Li, F., Lv, C., & Yang, Q. (2021) · Biology Direct · doi:10.1186/s13062-021-00294-7 · Cited by 87
mTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential
Lei, G., Zhuang, L., & Gan, B. (2021) · BioEssays · doi:10.1002/bies.202100093 · Cited by 86
Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer
Wang, R., Liu, Z., Fan, Z., & Zhan, H. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216267 · Cited by 86
KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub
Scalera, S., Mazzotta, M., Cortile, C., Krasniqi, E., Maria, R. D., Cappuzzo, F., Ciliberto, G., & Maugeri‐Saccà, M. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.03.011 · Cited by 83
Ferroptosis in hepatocellular carcinoma: from bench to bedside
Tang, D., Kroemer, G., & Kang, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000390 · Cited by 81
Zhao, L., Wang, H., Hu, D., Hu, J.-H., Guan, Z.-R., Yu, L., Jiang, Y.-P., Tang, X., Zhou, Z.-H., Xie, T., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.08.018 · Cited by 81
Fighting Resilient Cancers with Iron
Chen, J. J. F., & Galluzzi, L. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.007 · Cited by 80
Xiao, L., Ma, X., Ye, L., Pan, S., Xiong, W., Bi, E., Wang, Q., Xian, M., Yang, M., Qian, J., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 80
Roles of YAP/TAZ in ferroptosis
Magesh, S., & Cai, D. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.05.005 · Cited by 79
ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK/mTOR pathway in melanoma
Wang, M., Zeng, G., Xiong, B., Zhu, X., Guo, J., Chen, D., Zhang, S., Guo, L., Guo, L., & Cai, L. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115554 · Cited by 79
Sahebkar, A., Foroutan, Z., Katsiki, N., Jamialahmadi, T., & Mantzoros, C. S. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155659 · Cited by 79
Kim, K.-S., Choi, B., Choi, H., Ko, M. J., Kim, D., & Kim, D. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01635-y · Cited by 78
Moreno, S. G., Laux, G., Brielmeier, M., Bornkamm, G. W., & Conrad, M. (2003) · Biological Chemistry · doi:10.1515/bc.2003.070 · Cited by 77
Shi, L., Chen, H., Chen, K., Zhong, C., Song, C., Huang, Y., Wang, T., Chen, L., Li, C., Huang, A., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3971 · Cited by 77
Li, L., Yang, X., Xu, H., Yu, T., Li, Q., Hu, J., Peng, X., Han, N., Xu, X. M., Chen, N., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301561 · Cited by 77
Self-citationHedyotis diffusa injection induces ferroptosis via the Bax/Bcl2/VDAC2/3 axis in lung adenocarcinoma
Huang, F., Pang, J., Xu, L., Niu, W., Zhang, Y., Li, S., & Li, X. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154319 · Cited by 76
Hu, Q., Dai, J., Zhang, Z., Yu, H., Zhang, J., Zhu, X., Qin, Y., Zhang, L., & Zhang, P. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1999 · Cited by 76
The balancing act of NEET proteins: Iron, ROS, calcium and metabolism
Nechushtai, R., Karmi, O., Zuo, K., Marjault, H., Darash‐Yahana, M., Sohn, Y., King, S. D., Zandalinas, S. I., Carloni, P., & Mittler, R. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118805 · Cited by 75
Alam, N. A., Olpin, S. E., Rowan, A., Kelsell, D. P., Leigh, I. M., Tomlinson, I. P. M., & Weaver, T. M. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60574-0 · Cited by 74
Fueling the Tumor Microenvironment with Cancer-Associated Adipocytes
Bouche, C., & Quail, D. F. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0505 · Cited by 73
GINS4 suppresses ferroptosis by antagonizing p53 acetylation with Snail
Chen, L., Cai, Q., Yang, R., Wang, H., Ling, H., Li, T., Liu, N., Wang, Z., Sun, J., Tao, T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219585120 · Cited by 72
Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy
Zhu, S., Yang, N., Wu, J., Wang, X., Wang, W., Liu, Y.-J., & Chen, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104980 · Cited by 71
Self-citationLi, B., Wei, S., Yang, L., Peng, X., Ma, Y., Wu, B., Fan, Q., Yang, S., Li, X., Jin, H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.657723 · Cited by 69
Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
Liu, X., Zhong, S., Qiu, K., Chen, X., Wu, W., Zheng, J., Liu, Y., Wu, H., Fan, S., Nie, D., et al. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00411-4 · Cited by 69
Self-citationDihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage
Li, L., Peng, X., Yu, T., Xu, H., Han, N., Yang, X., Li, Q.-R., Hu, J., Liu, B., Yang, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.949835 · Cited by 68
Self-citationZhang, L., Hobeika, C. S., Khabibullin, D., Yu, D., Filippakis, H., Alchoueiry, M., Tang, Y., Lam, H. C., Tsvetkov, P., Georgiou, G., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122840119 · Cited by 67
Anasagasti, M. J., Martin, J. J., Mendoza, L., Obrador, E., Estrela, J. M., McCuskey, R. S., & Vidal‐Vanaclocha, F. (1998) · Hepatology · doi:10.1002/hep.510270510 · Cited by 65
Jiang, F., Jia, K., Chen, Y., Ji, C., Chong, X., Li, Z., Zhao, F., Bai, Y., Ge, S., Gao, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202300881 · Cited by 65
Zhang, X., Zheng, Q., Yue, X., Yuan, Z., Ling, J., Yuan, Y., Liang, Y., Sun, A., Liu, Y., Li, H., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02288-3 · Cited by 63
Self-citationChuang, G. S., Martı́nez-Mir, A., Geyer, A. S., Engler, D. E., Gläser, B., Cserhalmi‐Friedman, P. B., Gordon, D., Horev, L., Lukash, B., Herman, E., et al. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.08.051 · Cited by 60
Lippmann, J., Petri, K., Fulda, S., & Liese, J. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100785 · Cited by 60
Zhang, Y., Tan, Y., Liu, S., Yin, H., Duan, J., Fan, L., Zhao, X., & Jiang, B. (2022) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2022.2075297 · Cited by 60
Cui, Z., Wang, H., Li, S., Qin, T., Shi, H., Ma, J., Li, L., Yu, G., Jiang, T., & Li, C. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.09.008 · Cited by 59
Ghosh, M. K., Mukhopadhyay, M., & Chatterjee, I. B. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006841228483 · Cited by 56
Glutathione in metastases: From mechanisms to clinical applications
Estrela, J. M., Ortega, Á., Mena, S., Sirerol, J. A., & Obrador, E. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1136259 · Cited by 56
Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and Progression
Bansal, A., Sanchez, D. J., Nimgaonkar, V. U., Sánchez, D. L., Riscal, R., Skuli, N., & Simon, M. C. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1204 · Cited by 56
Cisplatin Promotes the Efficacy of ICI Therapy by Inducing Ferroptosis and Activating Neutrophils
Zhou, Z., Zhao, Y., Chen, S. X., Cui, G., Fu, W., Li, S., Lin, X., & Hu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.870178 · Cited by 55
Park, S., Jeong, K. J., Poire, A., Zhang, D., Tsang, Y. H., Blucher, A., & Mills, G. B. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06042-1 · Cited by 55
Han, L., Li, L., & Wu, G. (2022) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2022.101821 · Cited by 54
Yu, Y., Huang, Z., Chen, Q., Zhang, Z., Jiang, H., Gu, R., Ding, Y., & Hu, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121724 · Cited by 53
Rao, Z., Xia, Y., Jia, Q., Zhu, Y., Wang, L., Liu, G., Liu, X., Yang, P., Ning, P., Zhang, R., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01998-w · Cited by 52
CD8+ T cells PUF(A)ing the flames of cancer ferroptotic cell death
Angeli, J. P. F., da Silva, T. N. X., & Schilling, B. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.03.003 · Cited by 51
Wu, L., Liu, F., Yin, L., Wang, F., Shi, H. M., Zhao, Q., Yang, F., Chen, D., Dong, X., Gu, Y., et al. (2022) · 癌症:英文版 · doi:10.1002/cac2.12321 · Cited by 50
Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma
Zhao, L., Gong, Z.-Q., Zhang, Q., He, D., Ge, R., Jin, M., Ren, H., Fan, Y., & Wang, Z. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.035 · Cited by 49
Interferon-γ induces cancer cell ferroptosis
Zitvogel, L., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0186-z · Cited by 48
Radiotherapy-induced ferroptosis for cancer treatment
Beretta, G. L., & Zaffaroni, N. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1216733 · Cited by 47
Geiger, P. G., Thomas, J. P., & Girotti, A. W. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90250-m · Cited by 46
How erastin assassinates cells by ferroptosis revealed
Gan, B. (2022) · Protein & Cell · doi:10.1093/procel/pwac007 · Cited by 46
Polyunsaturated fatty acids, part 2: Biotransformations and biotechnological applications
Gill, I., & Valivety, R. H. (1997) · Trends in biotechnology · doi:10.1016/s0167-7799(97)01077-9 · Cited by 45
Liu, Z., Jiang, X., Gao, L., Liu, X., Li, J., Huang, X., & Zeng, T. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.04.180 · Cited by 42
Inhibition of ALG3 stimulates cancer cell immunogenic ferroptosis to potentiate immunotherapy
Liu, P., Lin, C., Liu, Z., Zhu, C., Lin, Z., Xu, D., Chen, J., Huang, Q., Li, C., Hou, L., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04365-4 · Cited by 42
The role of B-cell ferroptosis in the pathogenesis of systemic lupus erythematosus
Chen, Q., Xiang, M., Gao, Z., Lvu, F., Sun, Z., Wang, Y., Shi, X., Xu, J., Wang, J., & Liang, J. F. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109778 · Cited by 42
Vučetić, M., Daher, B., Cassim, S., Meira, W., & Pouysségur, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02994-w · Cited by 40
Yang, C., Chen, Z., Wei, M., Hu, S., Cai, M., Wang, N., Guan, Y., Li, F., Ding, Q., & Ling, D. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.030 · Cited by 40
Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer
Kerkhove, L., Geirnaert, F., Rifi, A. L., Ka, L. L., Gutiérrez, A., Oudaert, I., Corbet, C., Gevaert, T., Dufait, I., & Ridder, M. D. (2023) · Cancers · doi:10.3390/cancers15082363 · Cited by 40
Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis
Zeng, F., Ye, L., Zhou, Q., He, Y., Zhang, Y., Deng, G., Chen, X., & Liu, H. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102653 · Cited by 39
Self-citationLiang, H., Zhong, Y., Tan, C.-P., & Mao, Z. (2021) · Chemical Communications · doi:10.1039/d1cc01062j · Cited by 36
PM2.5 caused ferroptosis in spermatocyte via overloading iron and disrupting redox homeostasis
Wang, J., Zhang, Z., Shi, F., Li, Y.-Q., Tang, Y., Liu, C., Wang, Y., Chen, J., Xiao, J., Yang, H., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.162089 · Cited by 36
Structures of Atm1 provide insight into [2Fe-2S] cluster export from mitochondria
Li, P., Hendricks, A. L., Wang, Y., Villones, R. L. E., Lindkvist‐Petersson, K., Meloni, G., Cowan, J. A., Wang, K., & Gourdon, P. E. (2022) · Nature Communications · doi:10.1038/s41467-022-32006-8 · Cited by 35
Lai, X., Shi, Y., & Zhou, M. (2023) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12684 · Cited by 34
He, H., Liang, L., Huang, J., Jiang, S., Liu, Y., Sun, X., Li, Y., Li, C., & Jiang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1007429 · Cited by 33
Self-citationThe PTBP1‑NCOA4 axis promotes ferroptosis in liver cancer cells
Yang, H., Sun, W., Bi, T., Wang, Q., Wang, W., Xu, Y., Liu, Z., & Li, J. (2023) · Oncology Reports · doi:10.3892/or.2023.8482 · Cited by 33
UTP11 deficiency suppresses cancer development via nucleolar stress and ferroptosis
Gan, Y., Deng, J., Hao, Q., Huang, Y., Han, T., Xu, J.-G., Zhao, M., Yao, L., Xu, Y., Xiong, J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102705 · Cited by 33
Self-citationMa, H., Liu, Y., Miao, Z., Cheng, S., Zhu, Y., Wu, Y., Fan, X., Yang, J., Li, X., & Guo, L. (2022) · Drug Development Research · doi:10.1002/ddr.21983 · Cited by 32
Self-citationChen, Y., Tao, H., Wang, F., Wu, P., Gao, J., Zhang, X., He, Z., Zhou, Z., & Jia, Y. (2023) · Oncology Reports · doi:10.3892/or.2023.8584 · Cited by 32
Chen, K., Gu, L., Zhang, Q., Luo, Q., Guo, S., Wang, B., Gong, Q., & Luo, K. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121643 · Cited by 32
Lehrke, M. J., Shapiro, M. J., Rajcula, M. J., Kennedy, M. M., McCue, S. A., Medina, K. L., & Shapiro, V. S. (2021) · eLife · doi:10.7554/elife.69621 · Cited by 29
Multifunctional Nanomaterials for Ferroptotic Cancer Therapy
Shi, Z., Zheng, J., Tang, W., Bai, Y., Zhang, L., Xuan, Z., Sun, H., & Shao, C. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.868630 · Cited by 28
Belavgeni, A., Tonnus, W., & Linkermann, A. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01593-3 · Cited by 28
ER Stress in Dendritic Cells Promotes Cancer
Garris, C., & Pittet, M. J. (2015) · Cell · doi:10.1016/j.cell.2015.06.006 · Cited by 23
A dendritic-cell brake on antitumour immunity
Mérad, M., & Salmon, H. (2015) · Nature · doi:10.1038/523294a · Cited by 21
The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer
Bakadlag, R., Jandaghi, P., Hoheisel, J. D., & Riazalhosseini, Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1606904 · Cited by 21
Chang, H., Shapiro, J. S., Jiang, X., Senyei, G. D., Sato, T., Geier, J., Sawicki, K. T., & Ardehali, H. (2021) · eLife · doi:10.7554/elife.65158 · Cited by 21
Li, Q., Liu, C., Deng, L., Xie, E., Yadav, N., Tie, Y., Zheng, C., & Deng, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10710 · Cited by 21
RNF2 promotes the progression of colon cancer by regulating ubiquitination and degradation of IRF4
Wang, J., Ouyang, X., Zhou, Z., Mao, S., Niu, X., Li, H., Xu, W. L., Song, Y., Cao, J., & Lai, B. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119162 · Cited by 19
Idei, U., Ohta, T., Yamatani, H., Seino, M., & Nagase, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411781 · Cited by 15
Chipurupalli, S., Jiang, P., Liu, X., Santos, J. L., Marcato, P., & Rosen, K. V. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06106-2 · Cited by 15
Yu, L., Luo, Y., Ding, X., Tang, M., Gao, H., Zhang, R., Chen, M., Liu, Y., Chen, Q., Ouyang, Y., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1146617 · Cited by 14
Self-citation
Metadata
- Authors
- Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-03-08
- Volume
- 9
- Issue
- 1
- Pages
- 55-55
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4392757206
- Cited by
- 890
- References
- 491
- FWCI
- 227.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.